Apr 2021 |
The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates |
The Journal of Infectious Diseases |
Research funded by EVAg, Published by EVAg end-user |
Apr 2021 |
Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen |
Journal of Clinical Medicine |
Research funded by EVAg, Published by EVAg partner |
Apr 2021 |
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy |
Journal of Infection |
Research funded by EVAg, Published by EVAg partner |
Apr 2021 |
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients |
Cell |
Research funded by EVAg, Published by EVAg end-user |
Mar 2021 |
COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 |
Biomolecules |
Research funded by EVAg, Published by EVAg partner |
Mar 2021 |
An Integrated Molecular Approach to Untangling Host–Vector–Pathogen Interactions in Mosquitoes (Diptera: Culicidae) From Sylvan Communities in Mexico |
Frontiers in Veterinary Science |
Research funded by EVAg, Published by EVAg partner |
Mar 2021 |
COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice |
Journal of Virology |
Research funded by EVAg, Published by EVAg end-user |
Mar 2021 |
Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study |
Allergy |
Research funded by EVAg, Published by EVAg end-user |
Mar 2021 |
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates |
Cell Reports |
Research funded by EVAg, Published by EVAg end-user |
Mar 2021 |
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples |
Clinical Microbiology and Infection |
Research funded by EVAg, Published by EVAg partner |
Mar 2021 |
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies |
Journal of Immunological Methods |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Feb 2021 |
Evaluation of a Trio Toscana Virus Real-Time RT-PCR Assay Targeting Three Genomic Regions within Nucleoprotein Gene |
Pathogens |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Feb 2021 |
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing |
International Journal of Environmental Research and Public Health |
Research funded by EVAg, Published by EVAg partner |
Feb 2021 |
16S rRNA gene sequencing of rectal swab in patients affected by COVID-19 |
PLoS ONE |
Research funded by EVAg, Published by EVAg partner |
Feb 2021 |
Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit |
Proceedings of the National Academy of Sciences |
Research funded by EVAg, Published by EVAg end-user |
Feb 2021 |
Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Feb 2021 |
Identification, Isolation, and Characterization of an Ectromelia Virus New Strain from an Experimental Mouse |
Virologica Sinica |
Research funded by EVAg, Published by EVAg partner |
Feb 2021 |
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models |
Cell Host & Microbe |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Jan 2021 |
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Jan 2021 |
Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Jan 2021 |
SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring |
Science of The Total Environment |
Research funded by EVAg, Published by EVAg partner |
Jan 2021 |
Identification of mosquitoes (Diptera: Culicidae) from Mexico State, Mexico using morphology and COI DNA barcoding |
Acta Tropica |
Research funded by EVAg, Published by EVAg partner |
Jan 2021 |
Establishment of an African green monkey model for COVID-19 and protection against re-infection |
Nature Immunology |
Research funded by EVAg, Published by EVAg end-user |
Jan 2021 |
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort |
Emerging Microbes & Infections |
Research funded by EVAg, Published by EVAg end-user |
Jan 2021 |
A nidovirus perspective on SARS-CoV-2 |
Biochemical and Biophysical Research Communications |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
Modeling intra-mosquito dynamics of Zika virus and its dose-dependence confirms the low epidemic potential of Aedes albopictus |
PLoS Pathogens |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
Vertebrate-Aedes aegypti and Culex quinquefasciatus (Diptera)-arbovirus transmission networks: Non-human feeding revealed by meta-barcoding and next-generation sequencing |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma |
|
Research funded by EVAg, Published by EVAg end-user |
Dec 2020 |
Bat-Borne Coronaviruses in Jordan and Saudi Arabia: A Threat to Public Health? |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro |
Molecules |
Research funded by EVAg, Published by EVAg end-user |
Dec 2020 |
Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly |
PLoS Pathogens |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis |
Nature |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge |
Scientific Reports |
Research funded by EVAg, Published by EVAg end-user |
Dec 2020 |
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis |
Nature Communications |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics |
Nature Communications |
Research funded by EVAg, Published by EVAg end-user |
Dec 2020 |
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase |
Virology Journal |
Research funded by EVAg, Published by EVAg end-user |
Dec 2020 |
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients |
Nature Communications |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
Syncytia formation by SARS‐CoV‐2‐infected cells |
The EMBO Journal |
Research funded by EVAg, Published by EVAg partner |
Dec 2020 |
The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis |
Biopreservation and Biobanking |
Research funded by EVAg, Published by EVAg partner |
Nov 2020 |
The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy |
|
Research funded by EVAg, Published by EVAg partner |
Nov 2020 |
Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window |
Journal of Proteome Research |
Research funded by EVAg, Published by EVAg end-user |
Nov 2020 |
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients |
European Heart Journal - Cardiovascular Pharmacotherapy |
Research funded by EVAg, Published by EVAg end-user |
Nov 2020 |
A simple method for detection of a novel coronavirus (SARS‐CoV‐2) using one‐step RT‐PCR followed by restriction fragment length polymorphism |
Journal of Medical Virology |
Research funded by EVAg, Published by EVAg end-user |
Oct 2020 |
Quantifying and mapping the burden of human and animal rabies in Iraq |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg partner |
Oct 2020 |
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Oct 2020 |
Detection of Usutu virus infection in wild birds in the United Kingdom, 2020 |
Eurosurveillance |
Research funded by EVAg, Published by EVAg partner |
Oct 2020 |
Differential pathogenesis of Usutu virus isolates in mice |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg end-user |
Oct 2020 |
Anti-Zika virus and anti-Usutu virus activity of human milk and its components |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg end-user |
Oct 2020 |
Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses |
Antiviral Research |
Research funded by EVAg, Published by EVAg end-user |
Oct 2020 |
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples |
Journal of Medical Virology |
Research funded by EVAg, Published by EVAg end-user |